IEQ Capital’s Werewolf Therapeutics HOWL Stock Holding History

IEQ Capital’s Portfolio HOWL Stock Details HOWL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,837	Closed	-$10.5K	–	1903
2025 Q1	$10.5K	Buy	+10,837	New	+$14.2K	﹤0.01%	1598

Other funds holding HOWL

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

IEQ Capital's HOWL Position: Q2 2025 in Review

IEQ Capital sold out of Werewolf Therapeutics (HOWL) in Q2 2025, closing a stake of 10,837 shares — an estimated $10.5K sold.

IEQ Capital first reported a position in HOWL in Q1 2025 and held it in 1 quarter. The position peaked at $10.5K in Q1 2025. 65 funds tracked by Wall St. Rank hold HOWL as of Q2 2025.

IEQ Capital reported no remaining Werewolf Therapeutics position as of Q2 2025 after selling out during the quarter.
IEQ Capital sold 10,837 Werewolf Therapeutics shares in Q2 2025, an estimated $10.5K.
IEQ Capital first reported a position in Werewolf Therapeutics in Q1 2025 and held it in 1 quarter.
IEQ Capital's Werewolf Therapeutics position peaked at $10.5K in Q1 2025.
65 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q2 2025.

Based on IEQ Capital's 13F filing for Q2 2025, filed 14 Aug 2025.